Maia Biotechnology earnings were -$23.3M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest MAIA earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$3.6M, up 30.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MAIA reported annual earnings of -$23.3M, with 17.6% growth.
What were Maia Biotechnology's earnings last quarter?
Maia Biotechnology (NYSEMKT: MAIA) reported Q4 2024 earnings per share (EPS) of -$0.12, up 70.73% year over year. Total MAIA earnings for the quarter were -$3.57 million. In the same quarter last year, Maia Biotechnology's earnings per share (EPS) was -$0.41.
As of the last Maia Biotechnology earnings report, Maia Biotechnology is currently losing money. Maia Biotechnology's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$23.25 million, a 17.61% increase year over year.
What was MAIA's earnings growth in the past year?
As of Maia Biotechnology's earnings date in Q1 2025, Maia Biotechnology's earnings has grown year over year. MAIA earnings in the past year totalled -$23.25 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.